Real-World check: does nivolumab help after bladder cancer surgery?
NCT ID NCT05779592
First seen Jun 02, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This study is observing about 400 people in Japan who received the drug nivolumab after surgery for muscle-invasive urothelial carcinoma, a type of bladder or urinary tract cancer. Researchers are tracking how long patients stay cancer-free, side effects, and how the treatment is actually used in everyday medical practice. The goal is to see if nivolumab works well outside of clinical trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE UROTHELIAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution
City, State, Japan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nivolumab
What this could lead to
If successful, this study could confirm that nivolumab is effective and safe as an adjuvant therapy for muscle-invasive urothelial carcinoma in real-world settings.
What could go wrong
This is an observational study, not a controlled trial, so results may be less definitive. It only includes Japanese patients, so findings may not apply to other populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.